Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
New study offers insights for optimizing CML treatment
Chronic Myeloid Leukemia (CML) is a disease more common in the elderly, marked by the excessive growth of immature white…
iCAN National Program strengthens profiling, data sharing, and biobanking in Finland
iCAN reached one of its important milestones at the end of 2023, when an agreement was signed between the universities…
Munasarjasyövän tietoisuuspäivän potilas-tutkijatapaaminen 7.5.2024
Briefly in English: iCAN is organizing a series of patient-researcher meetups. These events aim to gather patients, interested citizens, and…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding